stella
beta
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy — Stella
Home
/
HER2-positive Breast Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to HER2-positive Breast Cancer trials
Trial locations
(1 site)
China
Peking University People's Hospital, Beijing, Beijing Municipality